Kostolny Martin, Hoerer Juergen, Eicken Andreas, Dietrich Claudia, Schreiber Christian F, Lange Ruediger
Clinic of Cardiovascular Surgery, German Heart Center Munich, Technical University Munich, Germany.
Cardiol Young. 2007 Oct;17(5):517-22. doi: 10.1017/S104795110700100X. Epub 2007 Jul 18.
We describe the experience from a single institution with the Norwood sequence of palliation for hypoplasia of the left heart, emphasizing complications related to placement of a conduit from the right ventricle to the pulmonary arteries and their management.
Between November, 2002 and January, 2006, we palliated 32 patients with hypoplastic left heart syndrome or its variants by placing a conduit from the right ventricle to the pulmonary arteries. We reviewed retrospectively the charts and angiograms from these patients.
Hospital survival after construction of the conduit was 90.6%. There were 3 interstage deaths, of which 2 were likely due severe obstruction of the conduit. Stents were implanted into the proximal or medial portions of the conduits of 3 patients. Early revision of the distal anastomosis, and shortening the conduit, was performed early postoperatively in 2 patients. So far, 24 out 26 survivors of the first stage underwent a bi-directional cavopulmonary anastomosis after a mean interval of 4.3 plus or minus 1.4 months. Of these, 3 required a semi-urgent second stage of palliation because of worsening cyanosis, with one patient dying after the second stage. Completion of the Fontan circulation by insertion of an extracardiac conduit was performed in 8 patients at the mean age of 19.8 plus or minus 2.2 months. We were able to achieve biventricular repair in 1 patient, with aortic atresia, hypoplastic arch and ventricular septal defect, 4.3 months after the initial palliative procedure. Overall survival of the whole cohort of 32 patients was 78.9%, plus or minus 7.8%, at 5 months, and 74.3%, plus or minus 8.6%, up to 25 months.
The introduction of the conduit placed from the right ventricle to the pulmonary arteries has led to an improved outcome in the complex entity of hypoplastic left heart syndrome and its variants. Stenosis of the conduit, nonetheless, may account for significant interstage morbidity, and often requires intervention or early installation of the second stage of palliation.
我们描述了一家机构对左心发育不全进行诺伍德姑息手术序列的经验,重点关注与右心室至肺动脉导管置入相关的并发症及其处理。
2002年11月至2006年1月期间,我们通过置入右心室至肺动脉的导管,对32例左心发育不全综合征或其变异型患者进行了姑息治疗。我们回顾性分析了这些患者的病历和血管造影资料。
导管置入术后的院内生存率为90.6%。有3例患者在两期手术间隔期死亡,其中2例可能是由于导管严重阻塞。3例患者的导管近端或中段植入了支架。2例患者在术后早期对远端吻合口进行了早期修复并缩短了导管。到目前为止,26例一期手术幸存者中的24例在平均间隔4.3±1.4个月后进行了双向腔肺吻合术。其中,3例因青紫加重需要进行半紧急的二期姑息治疗,1例患者在二期手术后死亡。8例患者在平均年龄19.8±2.2个月时通过置入心外导管完成了Fontan循环。1例患有主动脉闭锁、主动脉弓发育不全和室间隔缺损的患者在初始姑息手术后4.3个月实现了双心室修复。32例患者的整个队列在5个月时的总体生存率为78.9%±7.8%,至25个月时为74.3%±8.6%。
右心室至肺动脉导管的引入改善了左心发育不全综合征及其变异型这一复杂疾病的治疗效果。尽管如此,导管狭窄可能导致显著的两期手术间隔期发病率,并且通常需要干预或早期进行二期姑息治疗。